A detailed history of Pathway Financial Advisers, LLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Pathway Financial Advisers, LLC holds 4,378 shares of CLBT stock, worth $98,592. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,378
Previous 260 1583.85%
Holding current value
$98,592
Previous $3.11 Million 91.63%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$11.61 - $17.52 $47,809 - $72,147
4,118 Added 1583.85%
4,378 $260,000
Q1 2024

May 29, 2024

BUY
$8.04 - $12.29 $2,090 - $3,195
260 New
260 $2.88 Million

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $4.27B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Pathway Financial Advisers, LLC Portfolio

Follow Pathway Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Financial Advisers, LLC with notifications on news.